日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

C-Reactive Protein Kinetics as Prognostic Biomarkers in Stage IV-Melanoma Treated With Immune Checkpoint Inhibitors in the Japanese Population: A Single-Center, Retrospective Cohort Study

C反应蛋白动力学作为日本人群中接受免疫检查点抑制剂治疗的IV期黑色素瘤患者的预后生物标志物:一项单中心回顾性队列研究

Horisaki, Ken; Yoshikawa, Shusuke; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio

Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Stage IV Melanoma Receiving Immune Checkpoint Inhibitors: A Single-Center Retrospective Study

改良格拉斯哥预后评分在接受免疫检查点抑制剂治疗的IV期黑色素瘤患者中的预后意义:一项单中心回顾性研究

Horisaki, Ken; Yoshikawa, Shusuke; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio

The Real-World Efficacy and Side Effects of Different Nivolumab Regimens in Japanese Patients with Advanced Melanoma: A Single-Center Retrospective Study

不同纳武利尤单抗治疗方案在日本晚期黑色素瘤患者中的真实世界疗效和副作用:一项单中心回顾性研究

Horisaki, Ken; Yoshikawa, Shusuke; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio

Comparison of Adjuvant and Salvage Therapy with Immune Checkpoint Inhibitors in Head and Neck Mucosal Melanoma Treated with Proton Beam Therapy: A Retrospective Cohort Study

质子束治疗头颈部黏膜黑色素瘤辅助治疗与挽救治疗联合免疫检查点抑制剂的比较:一项回顾性队列研究

Horisaki, Ken; Yoshikawa, Shusuke; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio

Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma study

基于7442名日本患者的黑色素瘤皮肤癌统计数据:日本黑色素瘤研究

Fujisawa, Yasuhiro; Yoshikawa, Shusuke; Takenouchi, Tatsuya; Mori, Shoichiro; Asai, Jun; Uhara, Hisashi; Ichigosaki, Yuki; Fujimura, Taku; Nakamura, Yoshiyuki; Nakamura, Yasuhiro; Ohno, Fumitaka; Fukumoto, Takeshi; Ozawa, Toshiyuki; Namikawa, Kenjiro; Sugihara, Satoru; Hoashi, Toshihiko; Shimauchi, Takatoshi; Sawada, Yu; Iwata, Hiroaki; Maeda, Taku; Miyagawa, Takuya; Shibayama, Yoshitsugu; Hatta, Naohito; Kishi, Akiko; Ishikawa, Masashi; Kawahira, Hisao; Katoh, Norito; Okuyama, Ryuhei

Correction to: Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma study

更正:基于7442名日本患者的黑色素瘤皮肤癌统计数据:日本黑色素瘤研究

Fujisawa, Yasuhiro; Yoshikawa, Shusuke; Takenouchi, Tatsuya; Mori, Shoichiro; Asai, Jun; Uhara, Hisashi; Ichigosaki, Yuki; Fujimura, Taku; Nakamura, Yoshiyuki; Nakamura, Yasuhiro; Ohno, Fumitaka; Fukumoto, Takeshi; Ozawa, Toshiyuki; Namikawa, Kenjiro; Sugihara, Satoru; Hoashi, Toshihiko; Shimauchi, Takatoshi; Sawada, Yu; Iwata, Hiroaki; Maeda, Taku; Miyagawa, Takuya; Shibayama, Yoshitsugu; Hatta, Naohito; Kishi, Akiko; Ishikawa, Masashi; Kawahira, Hisao; Katoh, Norito; Okuyama, Ryuhei

Comparison of efficacy and adverse events by treatment cycles of nivolumab and ipilimumab in Japanese melanoma patients: A single-center, retrospective study

比较日本黑色素瘤患者接受纳武利尤单抗和伊匹木单抗治疗不同疗程的疗效和不良事件:一项单中心回顾性研究

Horisaki, Ken; Yoshikawa, Shusuke; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio

Prognosis and Toxicity Stratified by Best Tumor Burden Change in Japanese Patients With Advanced Melanoma Treated With First-Line Programmed Cell Death Protein 1 Monotherapy

根据最佳肿瘤负荷变化对接受一线程序性细胞死亡蛋白1单药治疗的日本晚期黑色素瘤患者的预后和毒性进行分层分析

Horisaki, Ken; Yoshikawa, Shusuke; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio

Prognostic value of the CONUT score with immune checkpoint inhibitors as first-line therapy for metastatic malignant melanoma

CONUT评分在免疫检查点抑制剂作为转移性恶性黑色素瘤一线治疗中的预后价值

Horisaki, Ken; Yoshikawa, Shusuke; Mori, Shoichiro; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio

Predictors of Dermal Invasion and Sentinel Lymph Node Metastasis in Patients With Extramammary Paget's Disease Without Clinical Lymph Node Enlargement

无临床淋巴结肿大的乳房外Paget病患者真皮浸润和前哨淋巴结转移的预测因素

Horisaki, Ken; Yoshikawa, Shusuke; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio